Beneficial effects of serotonin precursors in postanoxic action myoclonus.
In two patients with postanoxic action myoclonus, L-tryptophan or a monoamine oxidase inhibitor induced a moderate improvement, but L-5-hydroxytryptophan had greater therapeutic effect. Methysergide, a potent blocker of serotonin receptors, consistently induced a marked deterioration in myoclonus. Pretreatment cerebrospinal fluid 5-hydroxyindoleacetic acid levels were reduced significantly in both patients. These findings suggest that postanoxic action myoclonus likely is associated with insufficient serotonergic activity in the central nervous system. Data are inadequate to determine whether this apparent insufficiency reflects structural changes in 5HT-containing raphe nuclei due to a direct anoxic damage to these structures of functional changes caused by a secondary reduction in the activity of intact serotonergic neurons.
D006916:5-Hydroxytryptophan / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D002230:Carbidopa / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D000860:Hypoxia / Q000150:complications*; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D008875:Middle Aged; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology; D012701:Serotonin / Q000096:biosynthesis; D013577:Syndrome; D014364:Tryptophan / Q000627:therapeutic use
D012701:Serotonin; D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D002230:Carbidopa; D008784:Methysergide